The importance of early cyclosporine levels in pediatric kidney transplantation

Clinical Transplantation

Volumn 10, Issue 6 I, 1996, Pages 482-486

  Matas, Arthur J ^a   Gillingham, Kristen J ^a   Chavers, Blanche M ^a   Nevins, Tom ^a   Kashtan, Cliff ^a   Mauer, S Michael ^a   Payne, William D ^a   Gruessner, Rainer ^a   Najarian, John S ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cyclosporine; Pediatric patients; Renal transplant

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; DRUG BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0030480156     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. ALMOND PS, GILLINGHAM KJ, SIBLEY R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992: 53: 316.
2. MATAS AJ, ALMOND PS, Moss A, et al. Effect of cyclosporine on renal function in kidney transplant recipients - Twelve-year follow-up. Clin Transpl (in press).
3. GRANGER DK, AMIN NB, SORENSON AL, et al. Cyclosporine levels impact early rejection episodes. Transpl Proc 1994: 26: 2513.
4. ALMOND PS, MATAS A, GILLINGHAM K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993: 55: 752.
5. CHAVERS BM, MATAS AJ, GILLINGHAM KJ, et al. Pediatric renal transplantation at the University of Minnesota: The cyclosporine years. In: TERASAKI PI, CECKA JM, eds. Clinical Transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1995, pp. 203-212.
6. MATAS AJ, CHAVERS BM, NEVINS TE, et al. Pediatric transplantation-recipient evaluation, preparation, and care: The University of Minnesota protocols. Kidney Int (in press).
7. SALOMON D, BRUNSON M, VANSICKLER J, et al. A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity. Transpl Proc 1991: 23: 1018.
8. SALOMON DR. Cyclosporine nephrotoxicity and long-term renal transplantation. Transpl Rev 1992: 6: 10.
9. HARMON WE, SULUIVAN EK. Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation. Kidney Int 1993: 44 (Suppl. 43): 550.
10. SOIN AS, RASMUSSEN A, JAMIESON NV, et al. CSA levels in the early posttransplant period - predictive of chronic rejection in liver transplantation? Transplantation 1995: 59: 1119.
11. FRIGERIO M, COSTANZO MR, GRONDA E. Early cyclosporine dosing impacts long-term survival following heart transplantation (abstract). San Francisco: International Society of Heart and Lung Transplantation, 1995.
12. PFAFF WW. HOWARD RJ, BRUNSON ME. et al. The relationship of cyclosporine blood concentrations to early rejection and graft survival in renal transplantation (abstract). Am Soc Transplant Surgeons, Chicago, 1991. Table 3 - Percentage of Rejection-Free Recipients, by Months Post-transplant and Transplant Number.